Dehydro Olmesartan Medoxomil is a pharmaceutical impurity related to the antihypertensive drug olmesartan medoxomil. It is characterized as a structural derivative containing an imidazole ring and a tetrazole moiety, with a molecular weight of approximately 540 g/mol and moderate lipophilicity.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 879562-26-2
Olmésartan médoxomil
active pharmaceutical ingredient
1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane
pharmaceutical impurity
Benzoic acid, 2-(hexahydro-1-methyl-1H-azepin-4-yl)hydrazide
pharmaceutical impurity
4-Chloro-3,5-dimethylphenol
antiseptic drug active ingredient
1-Acetamidoadamantane
pharmaceutical raw material
Cefepime
active pharmaceutical ingredient
Pilsicainide hydrochloride
active pharmaceutical ingredient
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-prop-1-en-2-yl-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
PSFJJUXSEHXDFN-UHFFFAOYSA-N
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(=C)C